Rare brain disease associated with promising MS drug remains an FDA concern

WASHINGTON (AP) - The risk of a rare brain disease and other infections remains the primary concern of U.S. regulators as they seek independent advice on whether to allow a promising multiple sclerosis drug back on the market, according to documents released Monday....More